Prosight Management as of June 30, 2021
Portfolio Holdings for Prosight Management
Prosight Management holds 46 positions in its portfolio as reported in the June 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Prothena Corp SHS (PRTA) | 13.6 | $22M | 422k | 51.41 | |
| Albireo Pharma | 6.5 | $10M | 295k | 35.18 | |
| Arena Pharmaceuticals Com New | 5.8 | $9.3M | 137k | 68.20 | |
| Haemonetics Corporation (HAE) | 5.6 | $8.9M | 134k | 66.64 | |
| Cue Biopharma (CUE) | 4.6 | $7.3M | 630k | 11.65 | |
| Encompass Health Corp (EHC) | 4.3 | $6.9M | 88k | 78.03 | |
| Aldeyra Therapeutics (ALDX) | 4.2 | $6.7M | 595k | 11.33 | |
| Kezar Life Sciences | 3.5 | $5.6M | 1.0M | 5.43 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 3.4 | $5.5M | 27k | 201.62 | |
| Exicure | 3.4 | $5.4M | 3.6M | 1.50 | |
| Zogenix Com New | 3.3 | $5.3M | 306k | 17.28 | |
| Zimmer Holdings (ZBH) | 3.2 | $5.1M | 32k | 160.83 | |
| Galapagos Nv Spon Adr (GLPG) | 3.1 | $5.0M | 72k | 68.89 | |
| Convey Hldg Parent | 2.9 | $4.7M | 410k | 11.38 | |
| Kalvista Pharmaceuticals (KALV) | 2.7 | $4.3M | 181k | 23.96 | |
| Meiragtx Holdings (MGTX) | 2.7 | $4.2M | 274k | 15.50 | |
| R1 Rcm | 2.4 | $3.8M | 172k | 22.24 | |
| Morphic Hldg (MORF) | 2.3 | $3.7M | 64k | 57.39 | |
| Iovance Biotherapeutics (IOVA) | 2.3 | $3.6M | 139k | 26.02 | |
| Metacrine Ord | 2.1 | $3.3M | 869k | 3.80 | |
| Proqr Thrapeutics N V Shs Euro (PRQR) | 1.8 | $2.8M | 420k | 6.74 | |
| Quantum Si Com Cl A (QSI) | 1.7 | $2.8M | 227k | 12.26 | |
| UnitedHealth (UNH) | 1.3 | $2.0M | 5.0k | 400.40 | |
| LHC | 1.2 | $2.0M | 9.9k | 200.24 | |
| Aurinia Pharmaceuticals (AUPH) | 1.1 | $1.7M | 130k | 12.96 | |
| Ati Physical Therapy Com Cl A | 1.0 | $1.7M | 173k | 9.54 | |
| Medtronic SHS (MDT) | 0.9 | $1.4M | 11k | 124.09 | |
| Irhythm Technologies (IRTC) | 0.8 | $1.3M | 20k | 66.34 | |
| Cellectis S A Spon Ads (CLLS) | 0.8 | $1.3M | 86k | 15.47 | |
| Oscar Health Cl A (OSCR) | 0.7 | $1.2M | 55k | 21.49 | |
| Albireo Pharma Call Call Option | 0.7 | $1.2M | 33k | 35.17 | |
| Evolent Health Cl A (EVH) | 0.7 | $1.1M | 52k | 21.13 | |
| Clover Health Investments Com Cl A (CLOV) | 0.7 | $1.1M | 79k | 13.32 | |
| Akumin | 0.6 | $1.0M | 328k | 3.15 | |
| Aurinia Pharmaceuticals Call Call Option | 0.5 | $871k | 67k | 12.96 | |
| Nuvation Bio Com Cl A (NUVB) | 0.5 | $854k | 92k | 9.31 | |
| Sio Gene Therapies Common | 0.4 | $699k | 256k | 2.73 | |
| Oncorus | 0.4 | $690k | 50k | 13.80 | |
| Option Care Health Com New (OPCH) | 0.4 | $610k | 28k | 21.88 | |
| Assembly Biosciences | 0.4 | $578k | 149k | 3.88 | |
| X4 Pharmaceuticals | 0.4 | $571k | 88k | 6.50 | |
| Reneo Pharmaceuticals (RPHM) | 0.3 | $513k | 55k | 9.34 | |
| Aptose Biosciences Com New | 0.3 | $442k | 133k | 3.32 | |
| Organogenesis Hldgs (ORGO) | 0.3 | $417k | 25k | 16.61 | |
| Cano Health Com Cl A | 0.2 | $281k | 23k | 12.11 | |
| Adma Biologics (ADMA) | 0.1 | $184k | 115k | 1.60 |
